City Therapeutics, Inc. Stock: price and insider trades · United States

City Therapeutics, Inc. is a listed company. Its insiders report their share dealings to SEC (Form 4). Over the twelve months to 20 October 2026, 8 filings were filed, from 3 insiders.

The flow runs one way only: 1 insider bought (1 purchase totalling €2.7M) and nobody sold on the market. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The largest single trade was a purchase of €2.7M by ARCH Venture Partners XII, LLC, published on 19 October 2026. On the buying side, the filings list 1 major shareholder among the declarants.

For context, the typical company on the same exchange (median of 5,454 companies) published 22 filings over the same period, against 8 filings here. Over the whole record (from 2026), the tally stands at 1 purchase and no sales.

Within a 30-day window, 1 purchase overlapped with buying by a second insider. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase. The most recent open-market purchase was published on 19 October 2026, 2 days ago.

For comparison within the same market, see the insider buying recorded at Applied Digital Corp. and Heico Corp. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.